Nov
29
2024

Join the 2025 Joint Transnational Call Webinar on 17 December

The European Rare Diseases Research Alliance (ERDERA) is delighted to invite researchers, patient advocates, and early career professionals to a key webinar on 17 December 2024, following the official launch of the 2025 Joint Transnational Call for Proposals for “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation” on 10 December.

Click here to register for the webinar.

This Webinar will:

  • Provide general information on the call, including its scientific goalsadministrative aspectssupport services, and patient engagement strategies.
  • Address your questions through two dedicated Q&A sessions.

Agenda (CET)

  • 14.00-14.10  Welcome and Introduction to ERDERA (Daria Julkowska)
  • 14.10-14.30  JTC 2025 Introduction (Ralph Schuster)
  • 14.30-14.40  Pre-clinical therapy development – Evaluators perspective (Christine Kinnon)
  • 14.40-15.00  Q&A – Round 1
  • 15.00-15.10  Patient engagement in research (Roseline Favresse, Avril Kennan)
  • 15.10-15.20  ERDERA expertise support services (Viviana Giannuzzi, Toni Andreu, Rima Nabbout)
  • 15.20-15.30  Data Hub and FAIR data (Marco Roos)
  • 15.30-15.50  Q&A – Round 2
  • 15.50-16.00  Closing remarks

Registration is mandatory

  • The registration deadline is 17 December 2024.
  • Upon submitting your registration, you will receive connection links and calendar invitations to ensure seamless participation.

Note: The webinar will be recorded, and the video recording will be made available exclusively to registered participants.

Don’t miss this chance to get ahead in the application process and ensure that your project stands out!

Find out more details about ERDERA’s Joint Transnational Call 2025 – Preliminary announcement here.

News & Press Releases

You might also be interested in

World Orphan Drug Congress Europe 2025

ERDERA’s Networking Support Scheme – Ethics Self Assessment Tutorial

ERDERA’s Networking Support Scheme opens to forge new rare disease and rare cancer alliances

“I hope ERDERA solidifies the mindset that no single group—be it clinicians, patients, researchers, public authorities, or private entities—can succeed alone”